Merakris Therapeutics

JOBS

IN THE PRESS

Bio NC

Merakris To Share Data from Fully Enrolled First Part of Two-Part Dermacyte® Liquid Clinical Trial

December 5, 2023

·

4 min read

Business

Wound Healing Technology Company Merakris Adds Two Executives to Leadership Team

August 15, 2023

·

5 min read

Bio NC

Merakris Announces Review in Biomedicines Medical Journal Highlights Therapeutic Potential of Cell-Free Amniotic Fluid

November 29, 2022

·

5 min read

Bio NC

Study in Modern Optometry Shows Effectiveness Of Merakris Therapeutics’ Eye Product, Opticyte® Matrix

March 24, 2022

·

3 min read

Business

Merakris and Dept. of Veterans Affairs Sign CRADA Agreement – Clinical Trial for Dermacyte® Wound Care Product To Begin Soon

February 8, 2022

·

4 min read

Bio NC

Merakris Announces Agreement With Miracles In Sight Eye Bank To Supply Opticyte® Repair Grafts to Eye Surgeons

July 20, 2021

·

3 min read

Policy

Merakris Therapeutics, Inc. Announces FDA Clearance for Dermacyte® Liquid Clinical Trial

May 25, 2021

·

6 min read

Bio NC

Merakris Therapeutics, LLC Announces the Commercial Launch of Dermacyte® Matrix and CMS Assignment of an HCPCS Code for Use as a Skin Graft Substitute

July 9, 2020

·

2 min read

Bio NC

Merakris Therapeutics, LLC Files Request With FDA for Pre-IND Meeting for Dermacyte® Amniotic Wound Care Liquid

January 30, 2020

·

3 min read